alexa Are national drug expenditure control policies compatible with a single European market?
Nursing & Health Care

Nursing & Health Care

Health Economics & Outcome Research: Open Access

Author(s): Rovira J

Abstract Share this page

Abstract Turning a set of independent national markets into a single market is by no means an easy undertaking, especially when the original situation is characterised by a high level of public intervention, as is the case in the drug markets. This article describes the recent trends and the present situation with regard to public intervention in the Spanish drug market, and the conflicts faced in the process of integration into the single European market. The main conclusion is that building a single market should not only mean the elimination of trade barriers among the countries concerned, but that it also necessitates addressing the problems derived from the regulatory policies applied by the national authorities of member states, which may conflict with the working of a single market.
This article was published in Pharmacoeconomics and referenced in Health Economics & Outcome Research: Open Access

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version